Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Other Working Capital Changes (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Other Working Capital Changes for 15 consecutive years, with -$261000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 74.46% to -$261000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.3 million, a 14.84% increase, with the full-year FY2024 number at $2.9 million, up 2710.0% from a year prior.
  • Other Working Capital Changes was -$261000.0 for Q3 2025 at Usana Health Sciences, down from $208000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $5.2 million in Q2 2023 to a low of -$7.2 million in Q3 2023.
  • A 5-year average of $311529.4 and a median of $252000.0 in 2025 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 190.58% in 2022, then crashed 695.77% in 2023.
  • Usana Health Sciences' Other Working Capital Changes stood at $4.0 million in 2021, then grew by 12.73% to $4.5 million in 2022, then increased by 12.14% to $5.0 million in 2023, then decreased by 17.74% to $4.1 million in 2024, then crashed by 106.34% to -$261000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Other Working Capital Changes are -$261000.0 (Q3 2025), $208000.0 (Q2 2025), and $252000.0 (Q1 2025).